HomeBusinessHealthcareGreenwich Lifesciences (GLSI) CEO On Latest Clinical Data
Greenwich Lifesciences (GLSI) CEO On Latest Clinical Data

The CEO of Greenwich Lifesciences (GLSI) Snehal Patel joins Nicole to discuss the company’s latest innovations, including the results of five years’ worth of clinical trial data revealing potential for new T Cell platform technology, which the company announced at the 2021 San Antonio Breast Cancer Symposium. Founded in 2006, Greenwich Lifesciences is a clinical stage biopharmaceutical company that focuses on developing cancer immunotherapy, including for breast cancer.

The Watch List

09 Dec 2021

ON AIR
7:30 pm
Trading 360
replay
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
ON AIR
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US